BRCA /Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer
Author:
Affiliation:
1. Department of Surgery Graduate School of Medicine Osaka University OsakaJapan
2. Department of Surgery Osaka Medical Center for Cancer and Cardio‐Vascular Diseases Osaka Japan
Publisher
Wiley
Subject
Cancer Research,Oncology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12652
Reference52 articles.
1. Development of molecularly targeted therapies in biliary tract cancers: Reassessing the challenges and opportunities
2. Treatment of borderline cases for curative resection of biliary tract cancer
3. Clinicopathological features of long-term survivors for advanced biliary tract cancer and impact of the number of lymph nodes involved
4. Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma
5. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Exosomal miR-141-3p Induces Gemcitabine Resistance in Biliary Tract Cancer Cells;Anticancer Research;2024-06-26
2. Improved detection of homologous recombination deficiency in Chinese patients with ovarian cancer: a novel non‐exonic single‐nucleotide polymorphism‐based next‐generation sequencing panel;Molecular Oncology;2023-03-16
3. LncRNA CACClnc promotes chemoresistance of colorectal cancer by modulating alternative splicing of RAD51;Oncogene;2023-03-11
4. Differential operation of MLH1/MSH2 and FANCD2 crosstalk in chemotolerant bladder carcinoma: a clinical and therapeutic intervening study;Molecular and Cellular Biochemistry;2022-11-24
5. GLI1-targeting drugs induce replication stress and homologous recombination deficiency and synergize with PARP-targeted therapies in triple negative breast cancer cells;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2022-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3